Characteristics of patients misdiagnosed with Alzheimer's disease and their medication use: An analysis of the NACC-UDS database

BMC Geriatrics

Volumn 13, Issue 1, 2013, Pages

  Gaugler, Joseph E ^a   Ascher Svanum, Haya ^b   Roth, David L ^c   Fafowora, Tolulope ^c   Siderowf, Andrew ^d   Beach, Thomas G ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b ELI LILLY AND COMPANY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d AVID RADIOPHARMACEUTICALS   (United States)

^e SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Alzheimer disease; Autopsy; Diagnosis; Misdiagnosis; Neuropathology

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; DIAGNOSTIC ERROR; FACTUAL DATABASE; FEMALE; HUMAN; INAPPROPRIATE PRESCRIBING; LONGITUDINAL STUDY; MALE; STANDARD; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DATABASES, FACTUAL; DIAGNOSTIC ERRORS; FEMALE; HUMANS; INAPPROPRIATE PRESCRIBING; LONGITUDINAL STUDIES; MALE;

EID: 84890374189     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-13-137     Document Type: Article

References (41)

1. Clinical features and multidisciplinary approaches to dementia care. Grand JH, Caspar S, Macdonald SW, J Multidiscip Healthc 2011 4 125 147 21655340
2. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Hyman BT, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Carrillo MC, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Thies B, Trojanowski JQ, Vinters HV, Montine TJ, Alzheimers Dement 2012 8 1 1 13 10.1016/j.jalz.2011.10. 007 22265587
3. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH, Alzheimers Dement 2011 7 3 263 269 10.1016/j.jalz.2011.03.005 21514250
4. Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010. Beach TG, Monsell SE, Phillips LE, Kukull W, J Neuropathol Exp Neurol 2012 71 4 266 273 10.1097/NEN.0b013e31824b211b 22437338
5. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. Lim A, Tsuang D, Kukull W, Nochlin D, Leverenz J, McCormick W, Bowen J, Teri L, Thompson J, Peskind ER, Raskind M, Larson EB, J Am Geriatr Soc 1999 47 5 564 569 10323650 (Pubitemid 29215585)
6. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's disease centers consortium on apolipoprotein E and Alzheimer's disease. Mayeux R, Saunders AM, Shea S, Mirra S, Evans D, Roses AD, Hyman BT, Crain B, Tang MX, Phelps CH, N Engl J Med 1998 338 8 506 511 10.1056/NEJM199802193380804 9468467 (Pubitemid 28103134)
7. Clinical criteria for the diagnosis of Alzheimer disease: still good after all these years. Ranginwala NA, Hynan LS, Weiner MF, White CL III, Am J Geriatr Psychiatry 2008 16(5 384 388
8. Diagnosis of Alzheimer's disease in a community hospital-based brain bank program. Pearl GS, South Med J 1997 90 7 720 722 10.1097/00007611-199707000- 00013 9225895 (Pubitemid 27304711)
9. Incorrect diagnosis of Alzheimer's disease. A clinicopathologic study. Klatka LA, Schiffer RB, Powers JM, Kazee AM, Arch Neurol 1996 53 1 35 42 10.1001/archneur.1996.00550010045015 8599556 (Pubitemid 26023282)
10. Treatable and reversible dementias: an update. Piccini C, Bracco L, Amaducci L, J Neurol Sci 1998 153 2 172 181 10.1016/S0022-510X(97)00289-X 9511876 (Pubitemid 28131045)
11. Potentially reversible conditions in 1000 consecutive memory clinic patients. Hejl A, Hogh P, Waldemar G, J Neurol Neurosurg Psychiatry 2002 73 4 390 394 10.1136/jnnp.73.4.390 12235305
12. Multiple pathologies are common in Alzheimer patients in clinical trials. Wang BW, Lu E, Mackenzie IR, Assaly M, Jacova C, Lee PE, Beattie BL, Hsiung GY, Can J Neurol Sci 2012 39 5 592 599 22931699
13. The validity of clinical diagnoses of dementia in a group of consecutively autopsied memory clinic patients. Gay BE, Taylor KI, Hohl U, Tolnay M, Staehelin HB, J Nutr Health Aging 2008 12 2 132 137 10.1007/BF02982566 18264641 (Pubitemid 351219630)
14. Clinicopathological analysis of dementia disorders in the elderly-an update. Jellinger KA, J Alzheimers Dis 2006 9 3 Suppl 61 70 16914845 (Pubitemid 44253299)
15. Clinicopathological concordance in dementia diagnostics. Brunnstrom H, Englund E, Am J Geriatr Psychiatry 2009 17 8 664 670 10.1097/JGP. 0b013e3181a6516e 19634210
16. Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies. Boxer AL, Boeve BF, Alzheimer Dis Assoc Disord 2007 21 4 79 S87 10.1097/WAD. 0b013e31815c345e 18090429 (Pubitemid 350307449)
17. Effects of prescribed medications on cognition and behavior in frontotemporal lobar degeneration. Irwin D, Lippa CF, Rosso A, Am J Alzheimers Dis Other Demen 2010 25 7 566 571 10.1177/1533317510382285 20930186
18. Are amyotrophic lateral sclerosis patients cognitively normal? Lomen-Hoerth C, Murphy J, Langmore S, Kramer JH, Olney RK, Miller B, Neurology 2003 60 7 1094 1097 10.1212/01.WNL.0000055861.95202.8D 12682312 (Pubitemid 36418766)
19. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Lomen-Hoerth C, Anderson T, Miller B, Neurology 2002 59 7 1077 1079 10.1212/WNL.59.7.1077 12370467
20. Abhorring the vacuum: use of Alzheimer's disease medications in frontotemporal dementia. Kerchner GA, Tartaglia MC, Boxer A, Expert Rev Neurother 2011 11 5 709 717 10.1586/ern.11.6 21728274
21. Dementia with Lewy bodies. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, Dickson D, Dubois B, Duda JE, Feldman H, Gauthier S, Halliday G, Lawlor B, Lippa C, Lopez OL, Machado JC, O'Brien J, Playfer J, Lancet Neurol 2004 3 1 19 28 10.1016/S1474-4422(03)00619-7 14693108 (Pubitemid 38018924)
22. Lewy body dementia: the litmus test for neuroleptic sensitivity and extrapyramidal symptoms. Baskys A, J Clin Psychiatry 2004 65 Suppl 11 16 22
23. Clinicopathologic study of Alzheimer's disease: Alzheimer mimics. Shim YS, Roe CM, Buckles VD, Morris JC, J Alzheimers Dis 2013 35 4 799 811 23481687
24. The Uniform Data Set (UDS): clinical and cognitive variables and descriptive data from Alzheimer Disease Centers. Morris JC, Weintraub S, Chui HC, Cummings J, Decarli C, Ferris S, Foster NL, Galasko D, Graff-Radford N, Peskind ER, Beekly D, Ramos EM, Kukull WA, Alzheimer Dis Assoc Disord 2006 20 4 210 216 10.1097/01.wad.0000213865.09806.92 17132964 (Pubitemid 44900933)
25. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, van Belle G, Berg L, Neurology 1991 41 4 479 486 10.1212/WNL.41.4.479 2011243
26. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, Neurology 1984 34 7 939 944 10.1212/WNL.34.7.939 6610841 (Pubitemid 14076461)
27. Neuropathological stageing of Alzheimer-related changes. Braak H, Braak E, Acta Neuropathol 1991 82 4 239 259 10.1007/BF00308809 1759558
28. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. Folstein MF, Folstein SE, McHugh PR, J Psychiatr Res 1975 12 189 198 10.1016/0022-3956(75)90026-6 1202204
29. Measurement of functional activities in older adults in the community. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S, J Gerontol 1982 37 3 323 329 10.1093/geronj/37.3.323 7069156 (Pubitemid 12117513)
30. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J, Neurology 1994 44 12 2308 2314 10.1212/WNL.44.12.2308 7991117 (Pubitemid 24382728)
31. Development and validation of a geriatric depression screening scale: a preliminary report. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO, J Psychiatr Res 1982 17 1 37 49 10.1016/0022-3956(82)90033-4 7183759 (Pubitemid 13123113)
32. Benefits of statins in cerebrovascular disease. Di Napoli M, Curr Opin Investig Drugs 2004 5 3 295 305 15083596
33. Frontotemporal dementia: therapeutic interventions. Mendez MF, Front Neurol Neurosci 2009 24 168 178 19182475
34. Hope abandoned: memantine therapy in frontotemporal dementia. Hodges JR, Lancet Neurol 2013 12 2 121 123 10.1016/S1474-4422(13)70001-2 23305744
35. Lewy Body Dementia Association, Inc, Treatment options http://www.lbda.org/content/treatment-options. Updated 2012. Accessed January 27th, 2013
36. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Rolinski M, Fox C, Maidment I, McShane R, Cochrane Database Syst Rev 2012 3 CD006504
37. SAS Institute Inc, Base SAS® 9.3 Procedures Guide Cary, NC: SAS Institute Inc 2011
38. Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease. Bloudek LM, Spackman DE, Blankenburg M, Sullivan SD, J Alzheimers Dis 2011 26 4 627 645 21694448
39. Diagnostic accuracy of 18 F-FDG and 11C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment. Zhang S, Han D, Tan X, Feng J, Guo Y, Ding Y, Int J Clin Pract 2012 66 2 185 198 10.1111/j.1742-1241.2011.02845.x 22257044
40. Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline. Grundman M, Pontecorvo MJ, Salloway SP, Doraiswamy PM, Fleisher AS, Sadowsky CH, Nair AK, Siderowf A, Lu M, Arora AK, Agbulos A, Flitter ML, Krautkramer MJ, Sarsour K, Skovronsky DM, Mintun MA, for the AV45-A17 Study Group, Alzheimer Dis Assoc Disord 2013 27 1 4 15 10.1097/WAD.0b013e318279d02a 23203162
41. Impact of beta-amyloid-specific florbetaben PET imaging on confidence in early diagnosis of Alzheimer's disease. Schipke CG, Peters O, Heuser I, Grimmer T, Sabbagh MN, Sabri O, Hock C, Kunz M, Kuhlmann J, Reininger C, Blankenburg M, Dement Geriatr Cogn Disord 2012 33 6 416 422 10.1159/000339367 22814208